DRUGS CAUSING DYSLIPOPROTEINEMIA
- 1 September 1998
- journal article
- review article
- Published by Elsevier in Endocrinology and Metabolism Clinics of North America
- Vol. 27 (3), 677-697
- https://doi.org/10.1016/s0889-8529(05)70033-5
Abstract
No abstract availableKeywords
This publication has 139 references indexed in Scilit:
- The Effects of Supraphysiologic Doses of Testosterone on Muscle Size and Strength in Normal MenNew England Journal of Medicine, 1996
- Corticosteroid withdrawal after liver transplantationSurgery, 1995
- Plasma lipid and plasma lipoprotein concentrations in low birth weight infants given parenteral nutrition with twenty or ten percent lipid emulsionThe Journal of Pediatrics, 1989
- A Comparison of the Effects of Hydrochlorothiazide and Captopril on Glucose and Lipid Metabolism in Patients with HypertensionNew England Journal of Medicine, 1989
- Rhabdomyolysis in Patients Receiving Lovastatin after Cardiac TransplantationNew England Journal of Medicine, 1988
- Short‐Term Effects of Beta Blockers Atenolol, Nadolol, Pindolol, and Propranolol on Lipoprotein Metabolism in Normolipemic SubjectsThe Journal of Clinical Pharmacology, 1987
- A Prospective Study of Dehydroepiandrosterone Sulfate, Mortality, and Cardiovascular DiseaseNew England Journal of Medicine, 1986
- Changes in Plasma Lipids and Lipoproteins during Isotretinoin Therapy for AcneNew England Journal of Medicine, 1985
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- General clinical toxicology of oral retinoidsJournal of the American Academy of Dermatology, 1982